Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2529271014 | Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2532651018 | Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | est un(e) (attribut) | Product containing dexamethasone sodium phosphate (medicinal product) | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a pour principe actif (attribut) | Dexamethasone ophthalmic preparation (substance) | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a pour principe actif (attribut) | Dexamethasone sodium phosphate (substance) | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a pour principe actif (attribut) | Corticosterone | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | est un(e) (attribut) | lidocaine | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a pour principe actif (attribut) | Lidocaine (substance) | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a pour principe actif (attribut) | Adrenal hormone agent (substance) | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a pour principe actif (attribut) | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | est un(e) (attribut) | Product containing dexamethasone in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | est un(e) (attribut) | Lidocaine-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a pour principe actif (attribut) | Dexamethasone (substance) | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a pour principe actif (attribut) | Lidocaine hydrochloride | false | Inferred relationship | Some | ||
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution (product) | a une forme pharmaceutique (attribut) | solution pour injection (forme pharmaceutique) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR